718 related articles for article (PubMed ID: 26432614)
1. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU
Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular docking studies of hybrid benzimidazole as α-glucosidase inhibitor.
Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F
Bioorg Chem; 2017 Feb; 70():184-191. PubMed ID: 28043716
[TBL] [Abstract][Full Text] [Related]
5. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
[TBL] [Abstract][Full Text] [Related]
6. Isatin based Schiff bases as inhibitors of α-glucosidase: Synthesis, characterization, in vitro evaluation and molecular docking studies.
Rahim F; Malik F; Ullah H; Wadood A; Khan F; Javid MT; Taha M; Rehman W; Ur Rehman A; Khan KM
Bioorg Chem; 2015 Jun; 60():42-8. PubMed ID: 25955493
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
Wang G; He D; Li X; Li J; Peng Z
Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
[TBL] [Abstract][Full Text] [Related]
8. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
9. Novel pyridine-2,4,6-tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type-2 diabetes mellitus: In vitro studies against yeast α- and β-glucosidase and in silico molecular modeling.
Rehman TU; Riaz S; Khan IU; Ashraf M; Bajda M; Gawalska A; Yar M
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29194730
[TBL] [Abstract][Full Text] [Related]
10. Syntheses of new 3-thiazolyl coumarin derivatives, in vitro α-glucosidase inhibitory activity, and molecular modeling studies.
Salar U; Taha M; Khan KM; Ismail NH; Imran S; Perveen S; Gul S; Wadood A
Eur J Med Chem; 2016 Oct; 122():196-204. PubMed ID: 27371923
[TBL] [Abstract][Full Text] [Related]
11. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
12. Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking.
Yar M; Bajda M; Shahzadi L; Shahzad SA; Ahmed M; Ashraf M; Alam U; Khan IU; Khan AF
Bioorg Chem; 2014 Jun; 54():96-104. PubMed ID: 24880489
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.
Rahim F; Ullah H; Javid MT; Wadood A; Taha M; Ashraf M; Shaukat A; Junaid M; Hussain S; Rehman W; Mehmood R; Sajid M; Khan MN; Khan KM
Bioorg Chem; 2015 Oct; 62():15-21. PubMed ID: 26162519
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Novel Triazinoindole-Based Thiourea Hybrid: A Study on α-Glucosidase Inhibitors and Their Molecular Docking.
Taha M; Alshamrani FJ; Rahim F; Hayat S; Ullah H; Zaman K; Imran S; Khan KM; Naz F
Molecules; 2019 Oct; 24(21):. PubMed ID: 31652777
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
Wang G; Chen M; Qiu J; Xie Z; Cao A
Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs.
Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM
Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors.
Wang G; Chen M; Wang J; Peng Y; Li L; Xie Z; Deng B; Chen S; Li W
Bioorg Med Chem Lett; 2017 Jul; 27(13):2957-2961. PubMed ID: 28506754
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
